![Feng Ren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Feng Ren
Algemeen Directeur bij
INSILICO MEDICINE CAYMAN TOPCO
Vermogen: 3 M $ op 31-05-2026
Profiel
Feng Ren is currently Co-Chief Executive Officer & Executive Director at InSilico Medicine Cayman TopCo since 2023 and Co-CEO, Director & Chief Scientific Officer at InSilico Medicine, Inc. Formerly, Dr. Ren was Director & Head-Chemistry at GSK Plc from 2007 to 2018 and Senior Vice President & Head-Chemistry & Biology at Shanghai Medicilon, Inc. from 2018 to 2021.
Education includes a doctorate from Harvard University in 2007, a graduate degree from National University of Singapore in 2004, and an undergraduate degree from the University of Science & Technology of China in 1998.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-12-2025 | 475.400 ( 0,08% ) | 3 M $ | 31-05-2026 |
Actieve functies van Feng Ren
| Bedrijven | Functie | Begin |
|---|---|---|
| INSILICO MEDICINE CAYMAN TOPCO | Algemeen Directeur | 01-06-2022 |
InSilico Medicine, Inc.
 InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Algemeen Directeur | - |
Eerdere bekende functies van Feng Ren
| Bedrijven | Functie | Einde |
|---|---|---|
| SHANGHAI MEDICILON INC. | Corporate Officer/Principal | 01-01-2021 |
| GSK PLC | Directeur/Bestuurslid | 01-01-2018 |
Opleiding van Feng Ren
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
96
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National University of Singapore
 National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Medicilon, Inc.
 Shanghai Medicilon, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and develop biotechnology drug discovery contract research organization | Commercial Services |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Technology Services |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Pharmaceuticals: MajorHealth Technology Develops therapeutic pipeline technology and AI software platform | Health Technology |
Kies MarketScreener 
